van der Dijs F - Search Results

1

Red cell distribution width as predictor for mortality in critically ill patients.

Meynaar IA, Knook AH, Coolen S, Le H, Bos MM, van der Dijs F, von Lindern M, Steyerberg EW. Meynaar IA, et al. Among authors: van der dijs f. Neth J Med. 2013 Nov;71(9):488-93. Neth J Med. 2013. PMID: 24218427 Free article.

2

The association of pre-eclampsia with the Duffy negative phenotype in women of West African descent.

Velzing-Aarts FV, van der Dijs FP, Muskiet FA, Duits AJ. Velzing-Aarts FV, et al. Among authors: van der dijs fp. BJOG. 2002 Apr;109(4):453-5. doi: 10.1111/j.1471-0528.2002.01181.x. BJOG. 2002. PMID: 12013168

3

Plasma choline and betaine and their relation to plasma homocysteine in normal pregnancy.

Velzing-Aarts FV, Holm PI, Fokkema MR, van der Dijs FP, Ueland PM, Muskiet FA. Velzing-Aarts FV, et al. Among authors: van der dijs fp. Am J Clin Nutr. 2005 Jun;81(6):1383-9. doi: 10.1093/ajcn/81.6.1383. Am J Clin Nutr. 2005. PMID: 15941891 Free article.

4

Curaçao patients with coronary artery disease have a higher prevalence of the HFE C282Y mutation.

Dijck-Brouwer DA, Hepkema BG, van der Dijs FP, Steward HN, de Windt-Hol JM, Muskiet FA. Dijck-Brouwer DA, et al. Among authors: van der dijs fp. West Indian Med J. 2004 Jun;53(3):143-6. West Indian Med J. 2004. PMID: 15352740

5

Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease.

Schnog JB, Teerlink T, van der Dijs FP, Duits AJ, Muskiet FA; CURAMA Study Group. Schnog JB, et al. Among authors: van der dijs fp. Ann Hematol. 2005 May;84(5):282-6. doi: 10.1007/s00277-004-0983-3. Epub 2004 Dec 14. Ann Hematol. 2005. PMID: 15599544

6

Optimization of folic acid, vitamin B(12), and vitamin B(6) supplements in pediatric patients with sickle cell disease.

van der Dijs FP, Fokkema MR, Dijck-Brouwer DA, Niessink B, van der Wal TI, Schnog JJ, Duits AJ, Muskiet FD, Muskiet FA. van der Dijs FP, et al. Am J Hematol. 2002 Apr;69(4):239-46. doi: 10.1002/ajh.10083. Am J Hematol. 2002. PMID: 11921017 Free article.

7

Low adjusted-dose acenocoumarol therapy in sickle cell disease: a pilot study.

Schnog JB, Kater AP, Mac Gillavry MR, Duits AJ, Lard LR, van Der Dijs FP, Brandjes DP, ten Cate H, van Eps LW, Rojer RA. Schnog JB, et al. Among authors: van der dijs fp, van eps lw. Am J Hematol. 2001 Nov;68(3):179-83. doi: 10.1002/ajh.1175. Am J Hematol. 2001. PMID: 11754399 Free article. Clinical Trial.

8

Estimated incidence of sickle-cell disease in Aruba and St. Maarten suggests cost-effectiveness of a universal screening programme for St. Maarten.

van Heyningen AM, Levenston MJ, Tamminga N, Scoop-Martijn EG, Wever RM, Verhagen AA, van der Dijs FP, Dijck-Brouwer DA, Offriinga PJ, Muskiet FA. van Heyningen AM, et al. Among authors: van der dijs fp. West Indian Med J. 2009 Sep;58(4):301-4. West Indian Med J. 2009. PMID: 20099768

9

Umbilical vessels of preeclamptic women have low contents of both n-3 and n-6 long-chain polyunsaturated fatty acids.

Velzing-Aarts FV, van der Klis FR, van der Dijs FP, Muskiet FA. Velzing-Aarts FV, et al. Among authors: van der dijs fp, van der klis fr. Am J Clin Nutr. 1999 Feb;69(2):293-8. doi: 10.1093/ajcn/69.2.293. Am J Clin Nutr. 1999. PMID: 9989695

10

High serum interleukin-8 levels in afro-caribbean women with pre-eclampsia. Relations with tumor necrosis factor-alpha, duffy negative phenotype and von Willebrand factor.

Velzing-Aarts FV, Muskiet FA, van der Dijs FP, Duits AJ. Velzing-Aarts FV, et al. Among authors: van der dijs fp. Am J Reprod Immunol. 2002 Nov;48(5):319-22. doi: 10.1034/j.1600-0897.2002.01087.x. Am J Reprod Immunol. 2002. PMID: 12516654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page